LVTX icon

LAVA Therapeutics
LVTX

Overview Fund Activity

18 hedge funds and large institutions have $95.5M invested in LAVA Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-6
Holders Change %
-25%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DCM
DAFNA Capital Management
California
+$1.48M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$635K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$141K
4
SFM
Sphera Funds Management
Israel
+$15.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$15.6K

Top Sellers

1
MIM
Monashee Investment Management
Massachusetts
-$3.02M
2
Millennium Management
Millennium Management
New York
-$950K
3
MS
Maven Securities
Jersey
-$851K
4
PVI
Pura Vida Investments
New York
-$820K
5
CCM
CAAS Capital Management
New York
-$456K
Name Holding Trade Value Shares
Change 		Shares
Change %
PHK
26
Point72 Hong Kong
Hong Kong
– -$142K -9,355 Closed
Point72 Asset Management
27
Point72 Asset Management
Connecticut
– -$84K -5,561 Closed
DKCM
28
Davidson Kempner Capital Management
New York
– -$30K -2,000 Closed
1
2